About the Event
Date:November 6–7, 2026
Location:Orlando, FL
Credit:To Be Announced
On Demand:Available
Member registration is open. General registration opens June 1.
The ACR Practice Innovation Summit 2026 is designed for rheumatology professionals seeking practical strategies to strengthen independent and community-based practice. The summit will feature expert-led sessions focused on practice management, reimbursement, workforce challenges, value-based care, advocacy, technology integration, operational efficiency, patient access, and financial sustainability.
Attendees will engage with thought leaders and peers in an interactive environment designed to foster collaboration, innovation, and real-world problem solving for rheumatology practices.
On-demand access will include recordings of select sessions and Q&A discussions following the meeting.
Target Audience
Rheumatologists, physicians, advanced practice providers, practice administrators, healthcare executives, billing and coding professionals, and other healthcare professionals involved in rheumatology practice operations and patient care.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Identify operational and financial strategies to improve rheumatology practice sustainability
- Discuss emerging reimbursement and payment models impacting rheumatology practices
- Evaluate approaches to improving patient access, workforce recruitment, and care delivery
- Describe innovative technologies and practice tools that support operational efficiency and quality improvement
- Apply advocacy and policy strategies relevant to independent and community-based rheumatology practice
Please see the Practice Innovation Summit 2025 section below for details about the 2025 event.
Program Schedule & Syllabi
ACR Convergence 2026 Online Program
To Be Announced
Registered attendees can access the syllabi during the meeting and for 12 months after the meeting. To access syllabi, login and go to My Learning.
Registration Fees
Registration is open.
Bundled with ACR Convergence 2026
Member Bundle Registration: $499
Registration fees are available until 11:59 PM ET on the dates below.
| Registration Type | Early Bird | Regular |
|---|---|---|
| Member | $599 | $699 |
| *Fellow in Training | $0 | $0 |
| Master / Emeritus | $0 | $0 |
| *Resident / Student | $0 | $0 |
| **Developing Country | $299 | $399 |
*Fellow-in-Training, Resident, and Student Members
This category includes physicians enrolled in or who have completed a training program in rheumatology or a related field within the past year, individuals enrolled in a residency program who are interested in rheumatology as a subspecialty, students enrolled in a graduate-level educational program in medicine or a related field, or students enrolled in a health professional program leading to a baccalaureate or graduate degree. To be eligible for the reduced fee, members must provide a letter from your program director, chief of service, or faculty advisor.
**Member from Developing Countries
To be eligible for the reduced fee, members from countries with low-income and lower-middle-income economies, as determined by the World Bank, must provide evidence of work and residence address.
Registration fees are available until 11:59 PM ET on the dates below.
| Registration Type | Early Bird | Regular |
|---|---|---|
| ACR Nonmember | $699 | $799 |
| ARP Nonmember | $699 | $799 |
| *Fellow in Training | $0 | $0 |
| *Resident / Student | $0 | $0 |
| **Developing Country | $399 | $499 |
*Nonmember Fellow-in-Training, Resident, and Student Members
This category includes physicians enrolled in or who have completed a training program in rheumatology or a related field within the past year, individuals enrolled in a residency program who are interested in rheumatology as a subspecialty, students enrolled in a graduate-level educational program in medicine or a related field, or students enrolled in a health professional program leading to a baccalaureate or graduate degree. To be eligible for the reduced fee, potential members must provide a letter from your program director, chief of service, or faculty advisor.
**Nonmember from Developing Countries
To be eligible for the reduced fee, nonmembers from countries with low-income and lower-middle-income economies, as determined by the World Bank, must provide evidence of work and residence address.
Registration Guidelines
Full payment is due at the time of registration.
Cancellations and Refund Request
Please refer to the ACR Convergence 2026 registration page for full cancellation and refund request details.
Hotel & Travel
Press Registration
The American College of Rheumatology welcomes members of the press to write about research presented at our meetings. Complimentary registration is provided to approved members of the press to allow them to attend sessions on site.
Press registration details coming soon.
Acknowledgement of Commercial Support
No commercial support was provided for this activity.
Complete CE and MOC information to be announced.
ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.
Nature of Financial Relationships
All individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:
- Advisor or review panel member
- Consultant
- Employee
- Officer or Board Member
- Grant/research support
- Speaker/honoraria includes speakers bureau, symposia, and expert witness
- Independent contractor
- Executive role and/or ownership interest
- Royalties and/or patient beneficiary
- Intellectual property/patents
- Stock options or bond holdings in a for-profit corporation or self-directed pension plan
- Private investigator
- Expert witness
- Equity interest
- Other: specify details
None: Has no relevant financial relationship(s) with ineligible companies to disclose.
The planning committee and faculty reported the following disclosures.
View ACR's ACCME disclosure practices
All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated.
Practice Innovation Summit 2026 Financial Relationships Disclosures to be announced.
The Practice Innovation Summit 2025 was an in-person event held from October 24–25, 2025, in Chicago, Illinois.
This inaugural pre-ACR Convergence practice management program is a must-attend event for rheumatology professionals seeking to build smarter, stronger, and financially sustainable practices. Designed specifically for clinicians, practice managers, and interprofessional team members in community and private practice settings, this dynamic two-day summit provides the actionable strategies and expert insights needed to build a thriving private practice in today’s evolving healthcare landscape.
*Select sessions will be available on demand after the meeting to registered Practice Innovation Summit attendees until October 31, 2026.
Target Audience
Rheumatologists in private/community settings, practice and office managers, advanced practice providers and interprofessional team members and professionals unable to attend ACR Convergence but looking for valuable business and clinical education.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Develop and implement a rheumatology infusion program by identifying facility requirements, staffing needs, and essential operational workflows.
- Improve patient care and experience through strategies that enhance patient flow, comfort, and quality during infusion therapy.
- Analyze and apply billing and reimbursement strategies for ancillary services to improve financial sustainability.
- Identify and evaluate ancillary revenue opportunities such as imaging, physical therapy, and clinical trials for integration into rheumatology practices.
- Integrate new team members effectively by designing workflows that incorporate advanced practice providers (APPs) and new physicians into patient care models.
- Negotiate and manage insurance contracts using data-driven strategies to secure favorable terms and prepare for value-based and risk-based payment models.
Program Schedule & Syllabi
ACR Convergence 2025 Online Program
Practice Innovation Summit Program 2025 Schedule
Registered attendees can access the syllabi during the meeting and for 12 months after the meeting. To access syllabi, login and go to My Learning.
Acknowledgement of Commercial Support
No commercial support was provided for this activity.
CE & MOC Information
Please note: This session is not eligible for CME credits through ACR.
Financial Relationships Disclosures
ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.
Nature of Financial Relationships
All individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:
- Advisor or review panel member
- Consultant
- Employee
- Officer or Board Member
- Grant/research support
- Speaker/honoraria includes speakers bureau, symposia, and expert witness
- Independent contractor
- Executive role and/or ownership interest
- Royalties and/or patient beneficiary
- Intellectual property/patents
- Stock options or bond holdings in a for-profit corporation or self-directed pension plan
- Private investigator
- Expert witness
- Equity interest
- Other: specify details
None: Has no relevant financial relationship(s) with ineligible companies to disclose.
The planning committee and faculty reported the following disclosures.
View ACR's ACCME disclosure practices
All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated.
Practice Innovation Summit 2025 Financial Relationships Disclosures to be announced.